Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design, synthesis, biological evaluation and molecular docking study of novel thieno[3,2-d]pyrimidine derivatives as potent FAK inhibitors
Ruifeng Wang, Sijia Yu, Xiangxin Zhao, et al.
European Journal of Medicinal Chemistry (2019) Vol. 188, pp. 112024-112024
Closed Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

A Review on Recent Advances in Nitrogen-Containing Molecules and Their Biological Applications
Nagaraju Kerru, Lalitha Gummidi, Suresh Maddila, et al.
Molecules (2020) Vol. 25, Iss. 8, pp. 1909-1909
Open Access | Times Cited: 1151
Novel pyridine and pyrimidine derivatives as promising anticancer agents: A review
Mohammed Albratty, Hassan A. Alhazmi
Arabian Journal of Chemistry (2022) Vol. 15, Iss. 6, pp. 103846-103846
Open Access | Times Cited: 100
Synthesis and biological activity of pyrimidines-containing hybrids: Focusing on pharmacological application
Elham Zarenezhad, Mojtaba Farjam, Aida Iraji
Journal of Molecular Structure (2021) Vol. 1230, pp. 129833-129833
Closed Access | Times Cited: 87
Pyrimidine: a review on anticancer activity with key emphasis on SAR
Aastha Mahapatra, Tanya Prasad, Tripti Sharma
Future Journal of Pharmaceutical Sciences (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 87
Progress in the Development of Small Molecular Inhibitors of Focal Adhesion Kinase (FAK)
Yang Lu, Haiying Sun
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 23, pp. 14382-14403
Closed Access | Times Cited: 72
Expedition of sulfur‐containing heterocyclic derivatives as cytotoxic agents in medicinal chemistry: A decade update
Kritika Laxmikeshav, Kumari Pooja, Nagula Shankaraiah
Medicinal Research Reviews (2021) Vol. 42, Iss. 1, pp. 513-575
Closed Access | Times Cited: 67
Drug Discovery Targeting Focal Adhesion Kinase (FAK) as a Promising Cancer Therapy
Xiaojing Pang, Xiujuan Liu, Yuan Liu, et al.
Molecules (2021) Vol. 26, Iss. 14, pp. 4250-4250
Open Access | Times Cited: 57
The Development of FAK Inhibitors: A Five-Year Update
Andrea Spallarossa, Bruno Tasso, Eleonora Russo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6381-6381
Open Access | Times Cited: 35
Targeting focal adhesion kinase (FAK) for cancer therapy: FAK inhibitors, FAK-based dual-target inhibitors and PROTAC degraders
Ming Yang, Hua Xiang, Guoshun Luo
Biochemical Pharmacology (2024) Vol. 224, pp. 116246-116246
Closed Access | Times Cited: 9
Novel N -bridged pyrazole-1-carbothioamides With Potential Antiproliferative Activity: design, synthesis, In Vitro and In Silico Studies
Islam H. El Azab, Essa M. Saied, Alaa A. Osman, et al.
Future Medicinal Chemistry (2021) Vol. 13, Iss. 20, pp. 1743-1766
Closed Access | Times Cited: 32
Focal adhesion kinase—An emerging viable target in cancer and development of focal adhesion kinase inhibitors
Akshita Chauhan, Tabassum Khan
Chemical Biology & Drug Design (2020) Vol. 97, Iss. 3, pp. 774-794
Closed Access | Times Cited: 35
Design, synthesis and biological evaluation of novel benzofuran derivatives as potent LSD1 inhibitors
Xiangyu Zhang, Hai‐Lan Huang, Ziheng Zhang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 220, pp. 113501-113501
Open Access | Times Cited: 27
Focal adhesion kinase inhibitors in the treatment of solid tumors: Preclinical and clinical evidence
Patricia Quispe, Martín J. Lavecchia, Ignácio E. León
Drug Discovery Today (2021) Vol. 27, Iss. 2, pp. 664-674
Closed Access | Times Cited: 25
Design, synthesis, and biological evaluation of 2,4-diamino pyrimidine derivatives as potent FAK inhibitors with anti-cancer and anti-angiogenesis activities
Shan Wang, Rong‐Hong Zhang, Hong Zhang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 222, pp. 113573-113573
Closed Access | Times Cited: 24
Identification of Thieno[3,2-d]pyrimidine Derivatives as Dual Inhibitors of Focal Adhesion Kinase and FMS-like Tyrosine Kinase 3
Hanna Cho, Injae Shin, Hojong Yoon, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 16, pp. 11934-11957
Closed Access | Times Cited: 23
Identification of novel and potent PROTACs targeting FAK for non-small cell lung cancer: Design, synthesis, and biological study
Yin Sun, Ruifeng Wang, Yu Sun, et al.
European Journal of Medicinal Chemistry (2022) Vol. 237, pp. 114373-114373
Closed Access | Times Cited: 16
Design, synthesis and biological evaluation of 4-arylamino-pyrimidine derivatives as focal adhesion kinase inhibitors
Zhiwu Long, Yaqing Zuo, Rongrong Li, et al.
Bioorganic Chemistry (2023) Vol. 140, pp. 106792-106792
Closed Access | Times Cited: 8
FAK inhibitors in cancer, a patent review – an update on progress
Ya‐Xi Ye, Yuyao Cao, Lisheng Xu, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 8, pp. 593-610
Closed Access | Times Cited: 2
Discovery of 7H-pyrrolo[2,3-d]pyridine derivatives as potent FAK inhibitors: Design, synthesis, biological evaluation and molecular docking study
Ruifeng Wang, Xiangxin Zhao, Sijia Yu, et al.
Bioorganic Chemistry (2020) Vol. 102, pp. 104092-104092
Closed Access | Times Cited: 25
Facile One-Pot Multicomponent Synthesis of Pyrazolo-Thiazole Substituted Pyridines with Potential Anti-Proliferative Activity: Synthesis, In Vitro and In Silico Studies
Islam H. El Azab, Rania B. Bakr, Nadia A. A. Elkanzi
Molecules (2021) Vol. 26, Iss. 11, pp. 3103-3103
Open Access | Times Cited: 20
In Vitro Anticancer Activity Screening of Novel Fused Thiophene Derivatives as VEGFR-2/AKT Dual Inhibitors and Apoptosis Inducers
Rana M. Abdelnaby, Afaf El‐Malah, Rasha R. Fakhr Eldeen, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 6, pp. 700-700
Open Access | Times Cited: 13
Discovery of novel pyrrolo [2,3-d] pyrimidine derivatives as potent FAK inhibitors based on cyclization strategy
Shenxin Zeng, Shuai Yuan, Yu Zhang, et al.
Bioorganic Chemistry (2023) Vol. 139, pp. 106713-106713
Closed Access | Times Cited: 7
Inhibition of FLT3-ITD Kinase in Acute Myeloid Leukemia by New Imidazo[1,2-b]pyridazine Derivatives Identified by Scaffold Hopping
Petra Břehová, Eva Řezníčková, Kryštof Škach, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 16, pp. 11133-11157
Open Access | Times Cited: 6
FAK Inhibitors As Promising Anticancer Targets: Present and Future Directions
Muhamad Mustafa, Amer Ali Abd El‐Hafeez, Dalia A Abdelhafeez, et al.
Future Medicinal Chemistry (2021) Vol. 13, Iss. 18, pp. 1559-1590
Open Access | Times Cited: 15
Design, Synthesis, Biological Evaluation, and Molecular Docking of 2,4-Diaminopyrimidine Derivatives Targeting Focal Adhesion Kinase as Tumor Radiotracers
Yueheng Qi, Ye Li, Yu Fang, et al.
Molecular Pharmaceutics (2021) Vol. 18, Iss. 4, pp. 1634-1642
Closed Access | Times Cited: 14
Page 1 - Next Page

Scroll to top